Author
Listed:
- Shu-Mei Wan
- Narayanaswamy Balakrishnan
- Monica Mayeni Manurung
- Kwang-Hwa Chang
- Chien-Hua Wu
Abstract
The semi-blinded design can be applied for the adaptive design in clinical trials. According the the FDA guidance, an adaptive clinical design study would modify the study design and hypotheses based on the analysis of accrued data. An independent Data Monitoring Committee analyzes the unblinded data in the middle of a clinical trial and makes recommendations to the sponsor if any action is needed. The unblinded interim analysis could potentially introduce bias and put the integrity of the trial at risk. The proposed methodology is technically blinded for the interim analysis. In fact, actual treatment labels are not released. It is based on a treatment re-labeling approach in which the dummy treatments associated with the actual treatments via a pre-specified transition probability matrix are released in the dataset. The semi-blinded test statistic depends on this transition probability matrix. However, it can be evaluated without knowing the transition probability matrix if this matrix is a Latin square. As the stagnation probability approach to 0.5, the more information we will lose. It will lead to obtain a lower power of testing hypothesis, and may not be able to show the utility or efficacy of study treatment if this probability is close to 0.5. The higher the stagnation probability, the higher disclosure risk we have. The randomization codes may be broken as the stagnation probability approach to 1. The sponsor should strike a balance between the statistical power and disclosure risk.
Suggested Citation
Shu-Mei Wan & Narayanaswamy Balakrishnan & Monica Mayeni Manurung & Kwang-Hwa Chang & Chien-Hua Wu, 2023.
"Semi-blinded design in clinical trials,"
Communications in Statistics - Theory and Methods, Taylor & Francis Journals, vol. 52(20), pages 7165-7183, October.
Handle:
RePEc:taf:lstaxx:v:52:y:2023:i:20:p:7165-7183
DOI: 10.1080/03610926.2022.2042024
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:lstaxx:v:52:y:2023:i:20:p:7165-7183. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://www.tandfonline.com/lsta .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.